Q. Ping Dou

24.9k total citations · 3 hit papers
280 papers, 17.8k citations indexed

About

Q. Ping Dou is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Q. Ping Dou has authored 280 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Molecular Biology, 127 papers in Oncology and 59 papers in Pathology and Forensic Medicine. Recurrent topics in Q. Ping Dou's work include Ubiquitin and proteasome pathways (105 papers), Cancer-related Molecular Pathways (58 papers) and Tea Polyphenols and Effects (43 papers). Q. Ping Dou is often cited by papers focused on Ubiquitin and proteasome pathways (105 papers), Cancer-related Molecular Pathways (58 papers) and Tea Polyphenols and Effects (43 papers). Q. Ping Dou collaborates with scholars based in United States, China and Hong Kong. Q. Ping Dou's co-authors include Huanjie Yang, Di Chen, Qiuzhi Cindy Cui, Vesna Milacic, Sara M. Schmitt, Kristin R. Landis‐Piwowar, Michael Frezza, Tak Hang Chan, David M. Smith and Benyi Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Q. Ping Dou

277 papers receiving 17.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

2011 640 citations Q. Ping Dou et al. profile →
Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity

2006 572 citations Di Chen, Qiuzhi Cindy Cui et al. Cancer Research profile →
Novel Metals and Metal Complexes as Platforms for Cancer Therapy

2010 462 citations Q. Ping Dou et al. Current Pharmaceutical Design profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Q. Ping Dou	9.3k	6.2k	2.9k	2.4k	1.6k	280	17.8k
Ann M. Bode	12.4k 1.3×	4.1k 0.7×	1.1k 0.4×	2.4k 1.0×	3.3k 2.1×	422	21.1k
Kwang Seok Ahn	10.5k 1.1×	3.7k 0.6×	1.6k 0.5×	1.9k 0.8×	3.1k 2.0×	361	19.0k
William P. Steward	7.4k 0.8×	4.3k 0.7×	1.0k 0.4×	1.7k 0.7×	2.0k 1.2×	221	18.3k
Zigang Dong	17.1k 1.8×	5.7k 0.9×	1.3k 0.5×	3.1k 1.3×	4.4k 2.8×	578	28.0k
Jing‐Gung Chung	10.4k 1.1×	2.0k 0.3×	1.4k 0.5×	1.3k 0.6×	2.7k 1.7×	550	18.8k
Anupam Bishayee	9.5k 1.0×	2.3k 0.4×	1.3k 0.5×	1.6k 0.6×	2.3k 1.5×	312	20.2k
Rajesh Agarwal	10.5k 1.1×	2.4k 0.4×	808 0.3×	1.8k 0.8×	2.4k 1.5×	393	20.4k
Anne Monks	12.8k 1.4×	5.4k 0.9×	6.7k 2.4×	795 0.3×	2.3k 1.4×	103	24.4k
Fazlul H. Sarkar	18.9k 2.0×	9.9k 1.6×	2.6k 0.9×	4.0k 1.6×	9.0k 5.6×	466	33.7k
Jai‐Sing Yang	7.3k 0.8×	1.6k 0.3×	1.2k 0.4×	1.0k 0.4×	1.8k 1.1×	344	13.3k

Countries citing papers authored by Q. Ping Dou

Since Specialization

Citations

This map shows the geographic impact of Q. Ping Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q. Ping Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q. Ping Dou more than expected).

Fields of papers citing papers by Q. Ping Dou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Q. Ping Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q. Ping Dou. The network helps show where Q. Ping Dou may publish in the future.

Co-authorship network of co-authors of Q. Ping Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Q. Ping Dou. A scholar is included among the top collaborators of Q. Ping Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Q. Ping Dou. Q. Ping Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Y. H., et al.. (2025). FreqWave-TranDuD: A Multivariate Time Series Anomaly Detection Method Based on Wavelet and Fourier Transforms. IEEE Access. 13. 68384–68397. 1 indexed citations

Yu, Yan, Q. Ping Dou, Xuefei Wu, et al.. (2025). Immune Checkpoint Inhibitor–Induced Ureteritis and Cystitis in Patients With Lung Cancer and Uterine Malignancies: A Case Series and Literature Review. Journal of Immunotherapy. 49(3). 108–114. 1 indexed citations

Kushwaha, Narva Deshwar, et al.. (2025). Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects. Biomolecules. 15(2). 240–240. 2 indexed citations

Hu, Xia, et al.. (2025). Effect of pH on oxidation and hydrolysis of myofibrillar protein and the ability to bind heptanal. Food Research International. 217. 116841–116841. 1 indexed citations

Dou, Q. Ping, Weimin Qiu, Ming Xu, et al.. (2025). Multimodal ultrasound: a non-invasive method for identifying dedifferentiation of papillary thyroid carcinoma during active surveillance. Frontiers in Oncology. 15. 1545407–1545407.

Li, Yu, Q. Ping Dou, Bo Li, et al.. (2024). MicroRNAs as novel molecular targets of green tea polyphenol epigallocatechin-3-gallate (EGCG): relevance and importance to nutrition sciences and cancer prevention. Food Science and Human Wellness. 14(11). 9250317–9250317. 3 indexed citations

Hu, Guanghui, Jun Yu, Q. Ping Dou, et al.. (2024). High Prevalence of TBC1D12 5′UTR Mutations in Anaplastic Thyroid Cancer. Thyroid. 35(1). 115–119. 3 indexed citations

Martin, Tracey A., Lin Ye, Fiona Ruge, et al.. (2023). Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatment. Chinese Journal of Cancer Research. 35(4). 365–385. 7 indexed citations

Ye, Lin, Fiona Ruge, Ke Ji, et al.. (2023). Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential ‘Seed’ and ‘Soil’ Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers. International Journal of Molecular Sciences. 24(1). 876–876. 4 indexed citations

10.

Jiao, Peifu, et al.. (2020). Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019). Expert Opinion on Therapeutic Patents. 30(9). 677–694. 8 indexed citations

11.

Yang, Qingzhu, Kai Li, Lin Jiao, et al.. (2019). An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment. Current Pharmaceutical Design. 25(30). 3248–3256. 33 indexed citations

12.

Dou, Q. Ping, et al.. (2019). Multi-Channel Digital Oscilloscope Implementation over Android Device. Computer and Information Science. 12(2). 58–58. 1 indexed citations

13.

Liu, Gang, Andrea Renzetti, Pershang Farshi, et al.. (2016). Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines. Journal of Cellular Biochemistry. 117(10). 2357–2369. 30 indexed citations

14.

Shi, Xianping, Xin Chen, Xiaofen Li, et al.. (2013). Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation. Clinical Cancer Research. 20(1). 151–163. 114 indexed citations

15.

Yang, Huanjie, Ying Wang, Wenjuan Wu, et al.. (2013). Correction: Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo. PLoS ONE. 8(2). 1 indexed citations

16.

Zhang, Haijun, Di Chen, Wei Chen, et al.. (2010). Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo. Cancer Research. 70(10). 3996–4004. 94 indexed citations

17.

Shi, Guoqing, Di Chen, Guangshu Zhai, et al.. (2008). The Proteasome Is a Molecular Target of Environmental Toxic Organotins. Environmental Health Perspectives. 117(3). 379–386. 32 indexed citations

18.

Wali, Anil, Ying Wang, Zhandong Liu, et al.. (2007). Role of Ubiquitin-proteasome proteolytic pathway in malignant pleural mesothelioma.. Cancer Research. 67. 4406–4406. 1 indexed citations

19.

Chen, Di, Qiuzhi Cindy Cui, Huanjie Yang, & Q. Ping Dou. (2006). Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.. Cancer Epidemiology and Prevention Biomarkers. 15. 17 indexed citations

20.

Wan, Sheng, Di Chen, Q. Ping Dou, & Tak Hang Chan. (2004). Study of the green tea polyphenols catechin-3-gallate (CG) and epicatechin-3-gallate (ECG) as proteasome inhibitors. Bioorganic & Medicinal Chemistry. 12(13). 3521–3527. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact